Exec Chat: ResMed's CEO Mick Farrell Outlines 2025 Strategy For 250 Million Users
Executive Summary
ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.
You may also be interested in...
ResMed Ready To Supply Digital Answers To Health Care’s Demand Challenges
ResMed’s respiratory device portfolio has put it front and center of the global medtech industry’s efforts to bring COVID-19 under control. UK and Ireland country manager Antoine Valterio tells In Vivo how the company rose to the challenge, and how providers are now seeing digital technologies in a new light.
ResMed Ready To Supply The Digital Answers To Health Care’s Demand Challenges
ResMed’s respiratory device portfolio has put the company front and center of the global medtech industry’s efforts to bring COVID-19 under control. UK and Ireland country manager Antoine Valterio tells Medtech Insight how the company rose to the challenge, and how providers are now seeing digital technologies in a new light.
COVID-19: Medtronic Shares Ventilator Specs Amid Multi-Industry Efforts To Increase Ventilator Production
Medtronic shares an open-source design for its ventilator to help mitigate the nation’s ventilator shortage for COVID-19 patients.